Dr D Shakespeare

Give Feedback
Dr D Shakespeare

MBBS, MD, MRCP (UK), FRCR (UK). CCST (England)

Radiation Oncologist

Apollo Cancer Institutes
  • 20 Years of experience
  • English,Tamil
  • 1 Recommendations
  •  MON | 06:30 PM-07:00 PM Show More

Awards and Achievements

  • Various audits in Prostate,Lung.Brain tumours,Collorectal, and Breast Cancers.

 

Research and Publications

  • SBRT for early stage Lung cancer – outcomes from 5 years’ experience at James Cook Hospital Lung cancer 01/2013.
  • Brachytherapy for Prostate cancer Urological Cancer Abstracts. Issue No 26, Summer 2006.
  • Unraveling the causes of familial breast cancer, Advances in Breast cancer. Vol 3; Issue 4; Dec 2006.Stereo tactic Radiation in nonacademic center UK, Lung cancer 01/2015.

 

Qualification

MBBS, MD, MRCP (UK), FRCR (UK). CCST (England)

Work Experience

  • Working in Apollo since last assignment in UK.

 

Certifications & Professional Memberships

  • Tamilnadu Medical council
  • Association of Radiation Oncologist of India.
  • General medical council (Uk)
  • Royal college of Radiologists and Oncologists (Uk)

 

Medical Council Registration

52838

Special Interests

  • Head and neck tumours and Brain
  • Breast and thoracic malignancies
  • Male and female pelvic tumours{urology, gynecology, colorectal}
  • Expert in Cyber Knife, stereo tactic Radio surgery/Radiation (Benign and Malignant)
  • Knowledgeable about Particle therapy (Proton therapy- Christies UK 2017)

 

Summary

Dr Shakespeare trained in UK as a Radiation oncologist, has vast international and local experience in Radiation Oncology.

  • He is a specialist in all cutting edge radiation techniques including, 3D conformal Radiation, IMRT, IGRT, VMAT, Rapid arc and Tomotherapy.
  • Vastly experienced in cyber knife, stereo tactic radiosurgery and fractionatedstereotactic radiation.
  • Was pioneer in starting stereotactic Radiation in North east England.
  • Involved in formulating various Radiation guidelines with Royal College London.
  • Due to dual qualification of MRCP (UK) and FRCR (UK) has greater understanding about the role of chemotherapy and its potential interaction with Radiotherapyand its effects.
  • Research interest –was one of the principal investigators in SCORAD PIT STAMPEDE, SOCCAR multi centered phase 3 randomized trials.
  • Core member of various multi-disciplinary team meetings and grand tumour board.
  • Mentor and tutor for Radiation oncology national board trainees.

 


Treatments under RADIATION ONCOLOGIST

Radiation Therapy